Skip to main content
ARAY logo

ARAY · Accuray Inc

Track ARAY — free
$0.28 +0.00 (+0.98%) At close · Aug 14
Market Cap
$33.45M
Shares
118.96M

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Upcoming events

Date Event Type
2026-08-19 20:30 UTC Q4 2026 Accuray Incorporated Earnings Conference Call Earnings call

Recent news

Date Headline
2026-08-12 Accuray Advances Strategic Priorities Through Key Executive Leadership Appointments

MADISON, Wis., Aug. 12, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced two key leadership appointments intended to improve operational execution and profitability, deliver increased customer value, and enhance overall enterprise performance as the company continues to advance

2026-08-05 Accuray to Report Fourth Quarter Fiscal 2026 Financial Results on August 19, 2026

MADISON, Wis., Aug. 5, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the fourth quarter of fiscal year 2026, ended June 30, 2026, during a conference call hosted by company management at 1:30 p.m. PT / 4:30 p.m. ET on August 19, 2026.

2026-07-29 Accuray Announces Plan Involving Financial Strengthening, Strategic Partnerships, Technology Rollouts, and Operational Initiatives to Drive Long-Term Value Creation

MADISON, Wis., July 29, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY), a leading provider of radiation therapy systems for cancer treatment, today announced a plan incorporating several decisive actions that will drive a significant improvement in its financial position, a fundamental

2026-05-29 Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules

MADISON, Wis., May 29, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Paul Miele, the company's new Chief Commercial Officer and David Shin, the company's new Chief Legal Officer.

2026-05-15 Accuray and the University of Wisconsin-Madison Announce Master Research Agreement to Improve Personalized Care for Patients with Cancer

MADISON, Wis., May 15, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) and the University of Wisconsin School of Medicine and Public Health (UW SMPH) announced a new 10‑year strategic collaboration to advance personalized cancer treatments using Accuray's Stellar™ adaptive radiation

2026-05-06 Accuray Reports Fiscal 2026 Third Quarter Financial Results

MADISON, Wis., May 6, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third quarter ended March 31, 2026. Key Highlights Transformation plan delivering ahead of expectations, with approximately $10 million of cost and margin improvements

2026-04-22 Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026

MADISON, Wis., April 22, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2026, ended March 31, 2026, during a conference call hosted by company management at 1:30 p.m. PT / 4:30 p.m. ET on May 6, 2026.

2026-04-06 Accuray Appoints Paul Miele as Senior Vice President and Chief Commercial Officer

MADISON, Wis., April 6, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY), a leading provider of radiation therapy systems for cancer treatment, today announced the appointment of Paul Miele as Senior Vice President and Chief Commercial Officer, effective April 6, 2026.

2026-02-04 Accuray Reports Fiscal 2026 Second Quarter Financial Results

MADISON, Wis., Feb. 4, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the second quarter ended December 31, 2025. Key Highlights On December 15, 2025 the Company announced the first phase of comprehensive, strategic, operational, and

2026-01-21 Accuray to Report Second Quarter Fiscal 2026 Financial Results on February 4, 2026

MADISON, Wis. , Jan. 21, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the second quarter of fiscal year 2026, ended December 31, 2025 , during a conference call hosted by company management at 1:30 p.m. PT / 4:30 p.m. ET on February 4, 2026 .

2025-12-15 Accuray announces first phase of comprehensive strategic, operational, and organizational transformation plan; company expects first phase to improve annualized operating profitability by approximately $25 million and set the stage for renewed growth

Plan includes organizational realignment, rightsizing of cost structure, outsourcing, and sales enablement in order to enhance competitiveness and support long-term strategy. Workforce optimization actions will affect approximately 15% of the company's employees.

2025-11-05 Accuray Reports Fiscal 2026 First Quarter Financial Results

MADISON, Wis. , Nov. 5, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the first quarter ended September 30, 2025 . Key Highlights On October 20, 2025 , the Company announced accelerated transformation efforts, including: Appointed Steve La Neve

2025-10-31 Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules

MADISON, Wis. , Oct. 31, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Stephen La Neve , the company's new Chief Executive Officer. As a material inducement to Mr.

Past events

Source: https://investors.accuray.com/

Key facts CIK 1138723 CUSIP 004397105 13F (30d) 107 filings 105 filers Visit website Investor relations